Click it and Unblock the Notifications
Latest Updates
-
Purported Video of Muslim Mob Lynching & Hanging Hindu Youth In Bangladesh Shocks Internet -
A Hotel on Wheels: Bihar Rolls Out Its First Luxury Caravan Buses -
Bharti Singh-Haarsh Limbachiyaa Welcome Second Child, Gender: Couple Welcome Their Second Baby, Duo Overjoyed - Report | Bharti Singh Gives Birth To Second Baby Boy | Gender Of Bharti Singh Haarsh Limbachiyaa Second Baby -
Bharti Singh Welcomes Second Son: Joyous News for the Comedian and Her Family -
Gold & Silver Rates Today in India: 22K, 24K, 18K & MCX Prices Fall After Continuous Rally; Check Latest Gold Rates in Chennai, Mumbai, Bangalore, Hyderabad, Ahmedabad & Other Cities on 19 December -
Nick Jonas Dancing to Dhurandhar’s “Shararat” Song Goes Viral -
From Consciousness To Cosmos: Understanding Reality Through The Vedic Lens -
The Sunscreen Confusion: Expert Explains How to Choose What Actually Works in Indian Weather -
On Goa Liberation Day 2025, A Look At How Freedom Shaped Goa Into A Celebrity-Favourite Retreat -
Daily Horoscope, Dec 19, 2025: Libra to Pisces; Astrological Prediction for all Zodiac Signs
How The Team Behind The COVID-19 Vaccine Is Preparing For The Next Big Challenge
The Oxford AstraZeneca team, renowned for their pivotal role in developing the COVID-19 vaccine, is now turning its expertise towards an equally daunting challenge, creating the UK's first-ever vaccine against the bubonic plague. This ambitious endeavour comes as experts voice concerns over the resurgence of this deadly disease, historically known for decimating populations during the Black Death.
Today, the growing threat of antibiotic resistance is casting a shadow over the ability to treat the plague effectively, making the need for a vaccine more urgent than ever.
A Disease With A Dark History
The bubonic plague, caused by the Yersinia pestis bacteria, is one of the most infamous diseases in human history. Between 1346 and 1353, the Black Death swept through Europe, killing an estimated 200 million people. It remains one of the deadliest pandemics on record, reshaping societies across the globe. In the present day, while the plague is treatable with antibiotics, the rise of antibiotic-resistant strains has become a major cause for concern. In countries such as Madagascar and Peru, where resistant strains have been identified, the potential for the plague to evolve into a superbug is increasing, leaving experts to consider how best to prevent a global health crisis.
The Three Forms Of Plague
The plague manifests in three forms, each of which presents a significant threat to public health. The bubonic form, characterised by swollen and painful lymph nodes, has a mortality rate of approximately 30% without treatment. The pneumonic form, which affects the lungs, is much more dangerous, as it can spread from person to person through airborne droplets and can be fatal within 24 hours if untreated. The septicemic form, the rarest and most severe, occurs when the bacteria invade the bloodstream, leading to systemic infection. The ability of pneumonic plague to spread between humans makes it especially alarming, and the emergence of antibiotic resistance only heightens these risks.
Oxford's Promising Plague Vaccine Trials
In response to these mounting concerns, the Oxford Vaccine Group, led by Professor Sir Andrew Pollard, has initiated trials for a new plague vaccine. The study, which began in 2021, involved 40 healthy adults and has shown promising results so far, suggesting that the vaccine is both safe and capable of generating an immune response. While these findings are soon to undergo peer review, they offer hope that a viable solution to this ancient threat could soon be within reach. Despite some plague vaccines being licensed in Russia, the UK currently lacks an approved vaccine, relying on antibiotics as the primary line of defense.
The Growing Threat Of Antibiotic Resistance
One of the major motivations behind developing a plague vaccine is the growing challenge of antibiotic resistance. Professor Tim Atkins, a distinguished expert at the Defence Science and Technology Laboratory (DSTL), plays a pivotal role in advancing research on threats to national security, particularly focusing on biological and chemical defense strategies, has highlighted the risks posed by resistant strains of Yersinia pestis, noting that while the immediate threat to the UK may be low, the spread of resistant strains globally is a pressing concern. Resistance is not only limited to the plague but extends to common infections like MRSA, further underscoring the need for innovative approaches to combat bacterial infections.
A Global Effort To Protect Against Future Pandemics
The development of a plague vaccine is part of a broader global effort to prepare for future pandemics. Scientists at Porton Down's DSTL are advocating for accelerated vaccine development, recognising the critical importance of early intervention and preparedness. The COVID-19 pandemic has highlighted how swiftly global health threats can emerge, and the same principles must be applied to prevent the return of diseases like the plague.
The bubonic plague may seem like a disease of the past, but the risk of antibiotic resistance makes it a real and present danger. The work being done by the Oxford team to develop a plague vaccine represents a vital step in ensuring humanity is ready to tackle potential future health crises. Just as the world learned from the rapid spread of COVID-19, early intervention and scientific preparedness are key to avoiding disaster, particularly when it comes to diseases that have shaped history.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.
Continue with Google